Loading...
Please wait, while we are loading the content...
Similar Documents
Undetectable molecular residual disease after omacetaxine and nilotinib combination therapy in an imatinib-resistant chronic myeloid leukaemia patient harbouring the BCR-ABL1 T315I gatekeeper mutation
| Content Provider | Scilit |
|---|---|
| Author | Coude, Marie-Magdelaine Luycx, Odile Cariou, Marie-Estelle Maarek, Odile Dombret, Hervé Cayuela, Jean-Michel Rea, Delphine |
| Copyright Year | 2012 |
| Description | Journal: British Journal of Haematology |
| Ending Page | 410 |
| Starting Page | 407 |
| ISSN | 2573508X |
| e-ISSN | 13652141 |
| DOI | 10.1111/j.1365-2141.2011.09016.x |
| Journal | British Journal of Haematology |
| Issue Number | 3 |
| Volume Number | 157 |
| Language | English |
| Publisher | Wiley-Blackwell |
| Publisher Date | 2012-01-09 |
| Access Restriction | Open |
| Subject Keyword | Journal: British Journal of Haematology Leukaemia Therapy |
| Content Type | Text |
| Resource Type | Article |